Skip to content

Author

R. Höftberger

We have 4 of 316 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Epigenetic dysregulation of Th2 cytokine genes in MuSK myasthenia gravis and its modulation by immunosuppressive therapy

A role for epigenetic dysregulation of Th2-associated cytokines in the immunological environment associated with IgG4 subclass switch is support by this first study investigating IL4, IL10, and IL13 promoter DNA methylation in MuSK-MG.

Cansu Elmas, A. Stoccoro, Martina Lari et al. · 0 citations
Review Open access Aug 2026

MOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children

Children can develop the full spectrum of MOGAD-like encephalitis without MOG-IgG, including lesion distribution, frequency of associated longitudinally extensive transverse myelitis, lesion resolution, and functional outcomes.

G. Olivé-Cirera, E. Fonseca, M. Guasp et al. · 0 citations
Open access Aug 2026

A primary human muscle cell-based assay for detecting myasthenia gravis autoantibody binding and assessing AChR cluster impairment

A physiologically relevant human NMJ model based on primary human muscle cells is established that enables detection and functional characterization of neuromuscular autoantibodies and a novel muscle cell-based assay (CBA) for the detection of neuromuscular autoantibodies is developed.

Marlene Wolfsgruber, Anna-Sophie Zimmermann, Katja Starnberger et al. · 0 citations
Review Open access Aug 2026

Use of Fluid Biomarkers in NMOSD and MOGAD

A review of current evidence on established and emerging fluid biomarkers in NMOSD and MOGAD, with emphasis on analytical performance, biological relevance, and clinical utility, and outlines priorities for future research.

S. Mariotto, Á. Cobo-Calvo, M. Khalil et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.